HIGHLIGHTS
- who: Asthma Omalizumab Anti-IgE Allergy and collaborators from the Department of Dermatology and Allergy, Charitu00e9-Universitu00e4tsmedizin Berlin, Berlin, Germany University of Southampton School of Medicine have published the research work: Comparison of extended intervals and dose reduction of omalizumab for asthma control, in the Journal: (JOURNAL)
- what: This study evaluated control after either dosage interval extension or reduction in patients with controlled by Methods Thirty-seven patients were assigned to receive either extended treatment interval (n = or a reduction in dosage (n = This study evaluated the Comparison of extended intervals and dose reduction of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.